Upendra P. Hegde, MDProfessor of Medicine (in Residence)Co-Director, Melanoma and Cutaneous Oncology Program Co-Director, Head and Neck and Oral Oncology Program Director, Oncology Inpatient Unit
|
|
Education
Post-Graduate Training
Awards
Degree | Institution | Major |
---|---|---|
MBBS | Goa Medical College | Medicine, Surgery |
MD | Goa Medical College | General Medicine |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Residency | Goa Medical College and Hospital | Compulsory Rotatory |
Residency | Goa Medical College and Hospital | Psychiatry and Human Behavior |
Residency | Goa Medical College and Hospital | Internal Medicine |
Residency | Goa Medical College and Hospital | Internal Medicine |
Fellowship | Tata Memorial Cancer Hospital | Hematology/Oncology |
Fellowship | Tata Memorial Hospital | Hematology/Oncology |
Research Scholar | Rush University Cancer Institute | |
Residency | Cook County Hospital | Internal Medicine |
Fellowship | National Heart, Lung, and Blood Institute | Hematology and Medical Oncology |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Top Doctor in Connecticut 2023 | Connecticut Magazine |
Diplomate in Hematology Maintainance of Certification Board Examination, November 2022 | American Board of Internal Medicine |
Named Top Doctor, Connecticut Magazine Survey of Connecticut Doctors - 2022 | Connecticut Magazine |
EXCELLENCE IN TEACHING AWARD, SPECIALIST or CONSULTANT, 2020-2021 | UCONN Health, Primary Care Internal Medicine Residency Program |
Named Top Doctor, Connecticut Magazine Survey of Connecticut Doctors - 2021 | Connecticut Magazine |
Ranked amongst most highly by the Internal Medicine residents over the past academic year | Department of Medicine |
America's Top Doctors | Castle Connolly's |
Top Doctor in Connecticut Magazine 2017 | Connectictut Magazine |
Leonard Tow 2016 Humanism in Medicine Award | The Arnold P. Gold Foundation |
America’s Best Doctor | U.S. Public News |
Best Teaching Award, Hematology/Oncology Training Program, 2008-2009 | UConn Health Center |
PAWS Team Award, UConn Health Center | UConn Health Center Cares Council |
Recipient of Scholarship Towards ASCO/AACR Workshop | |
Humanitarian Resident Award | Cook County Hospital |
Humanitarian Resident Award, Chicago, Illinois, 1996-1997 | Cook County Hospital |
USMLE 1, 2, 3 | |
J.N. Tata Endowment Travel Scholarship | |
Research Scholarship, Chicago, Illinois, 1992-1995 | Rush University Cancer Institute |
Khandelwal Junior Oncology Award, Madras, India | Indian Society of Oncology |
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
American society of clinical oncology self-evaluation program (ASCO-SEP) question writing task force member | Other | Co-Chair | Other | National | 2023 | 2024 |
American Society of Clinical Oncology, Question Writing Group Member, ASCO's self-assessment programs | Education Committee | Member | External | National | 2020 | 2022 |
Institutional Review Board | Other | Co-Chair, Panel 2 | UConn Health | University | 2016 | |
Institutional Review Board | Professional/Scientific Organization | Co-Chairman Panel 2 | UConn Health | University | 2014 | |
Quality and Resource Management | Advisory Committee | Member | UConn Health | Local | 2014 | 2018 |
Search Committee for Faculty Recruitment | Education Committee | Committee Member | UConn Health | University | 2009 | |
Schwartz Round Planning and Patient Selection Committee | Professional/Scientific Organization | Member | UConn Health | University | 2009 | |
Scientific Review Committee for the Institutional American Cancer Society Research Award | Professional/Scientific Organization | Member | UConn Health | University | 2009 | |
Search Committee for Medical Oncology/Hematology Faculty Recruitment | Professional/Scientific Organization | Member | UConn Health | University | 2009 | |
Search Committee for Gynecologic Oncology Faculty Recruitment | Professional/Scientific Organization | Quality Assurance Liaison | UConn Health | University | 2009 | |
American Association for Cancer Research | Professional/Scientific Organization | Member | External | National | 2005 | |
Connecticut State Society of Medical Oncology | Professional/Scientific Organization | Member | External | State | 2003 | |
Cancer Registry and Quality Control Committee | Advisory Committee | Member | UConn Health | University | 2003 | |
American Society of Clinical Oncology | Professional/Scientific Organization | Member | External | National | 2000 | |
American Society of Hematology | Professional/Scientific Organization | Member | External | National | 1998 | 2003 |
Department of Medicine Q/A committee | Professional/Scientific Organization | Liaison | UConn Health | University |
Journal Articles
-
Genomic characterization of an esthesioneuroblastoma with spinal metastases: illustrative case.
Journal of neurosurgery. Case lessons 2023 Dec;6(23):
-
Radiation therapy for head and neck cancer leads to gingival recession associated with dental caries.
Oral surgery, oral medicine, oral pathology and oral radiology 2022 May;133(5):539-546
-
Association of advanced age and cancer history with autoimmune disease in melanoma patients: a cross-sectional study.
BMC Cancer 2021 Dec;21(1):1300
-
HER-2 Neu gene: A valuable therapeutic target in metastatic mucoepidermoid carcinoma.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2021 Jul;10781552211032722
-
Complete response of penile mycosis fungoides with systemic brentuximab therapy.
Urology case reports 2020 Oct;341-3
-
Intra-cranial bleeding following soccer related head trauma and occult factor VII deficiency in a young student.
Wiley Clinical Case Report 2020 Oct;8(11):2148-2151
-
The Salivary Mycobiome Contains 2 Ecologically Distinct Mycotypes.
Journal of dental research 2020 Apr;99(6):730-738
-
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Lancet (London, England) 2019 Nov;394(10212):1915-1928
-
Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy.
Journal of fungi (Basel, Switzerland) 2019 Jun;5(2):
-
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Nov;3752-60
-
pTregs or iTregs are the Potent Tolerance Inducer for the growth and Metastasis of Cancer
International Journal of Immunology and Immunotherapy 2018 Oct;5(031):
-
Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly.
Human Immunology 2013 May;74(5):640-7
-
Melanoma in the elderly patient: relevance of the aging immune system.
Clinics in Dermatology 2009 Jan;27(6):537-44
Book Chapters
-
Skin Cancers and Melanoma
The Bethesda Handbook of Clinical Oncology 2018 Jun;
-
Skin Cancers and Melanoma: Review questions
The Bethesda Review of Clinical Oncology 2018 Jun;205-220
-
Skin Cancers and Melanoma
The Bethesda Handbook of Clinical Oncology
Abstracts
-
Iatrogenic hyperhydration in sickle cell disease patients admitted for acute pain crisis management: a retrospective analysis from a single institution.
Blood (2023)142 (supplement 1):7214 2023 Nov;
-
Correlation of patient characteristics and tumor histology in patients (pts) with locally advanced cutaneous squamous cell carcinoma 9LACSCC) receiving immune checkpoint inhibitor treatment (ICI): A retrospective analysis
Journal of Clinical Oncology 2023 Jun;(e21553):
-
Influence of age and cancer history on prevalence of autoimmunity in patients with metastatic melanoma: A large retrospective study
Journal of Clinical Oncology. 38,2020. Proceedings of the 56th Annual Meeting of the American Society of Clinical Oncology 2020. 2020 May;38
-
Autoimmune toxicities with anti-PD-1 treatment of metastatic melanoma in predominantly older patients: A single institutional experience.
Journal of Clinical Oncology 2019 Mar;37(8):144
-
Clinical heterogeneity of elderly melanoma patients in the real-world setting: Potential implications for treatment outcomes following immune based therapy
Journal of Clinical Oncology 2019 Mar;37(15):e21026
-
Peripheral blood T-cell functional assay as a predictive biomarker of immune-therapy of metastatic melanoma.
Journal of Clinical Oncology 2018 Jun;36(Suppl abstr e21593):
-
Determination of the potential of detecting 3q gain as a valuable biomarker in the management of patients with human papilloma virus (HPV) associated oropharyngeal squamous cell carcinoma (OPSCC)
ASCO Annueal Meeting 2017 (suppl:abstr e17534)
-
Immune checkpoint inhibitor treatment of advanced age metastatic melanoma (MM patients.
ASCO Annual Meeting Abstracts 2017 (suppl;abstr e14603)
-
Outcome of metastatic melanoma following immune checkpoint inhibitor treatment by tumor infiltrating lymphocytes of primary cutaneous site
Journal of Clinical Oncology. (Suppl; e22005). 2020.(Suppl: e22005):
-
Outcome of metastatic melanoma following immune checkpoint inhibitor treatment by tumor infiltrating lymphocytes of primary cutaneous site
Journal of Clinical Oncology. (Suppl; e22005).Proceeding of the 56 annual meeting of the American Society of Clinical Oncology 2020 38
-
Quite breaking my heart; 5-Fluorouracil Associated Cardiomyopathy Presented by the first author at the national meeting of the Society of Internal Medicine in Washington 2017
National Meeting of the Society of Internal Medicine in Washington 2017
Case Reports
-
Nivolumab-induced lichen planus responsive to dupilumab treatment in a patient with stage III C melanoma.
JAAD Case Reports 2023 Aug;3823-26
-
Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving Pembrolizumab
Journal of Oncology Pharmacy Practice 2020 May;27(1):207-211
-
Bilateral spontaneous subdural hematomas as the initial presentation of von Willebrand Disease: A case report and review of the literature
-
High-risk human papilloma virus induced oropharyngeal squamous cell carcinoma following immune suppressive treatment of multiple sclerosis: Challenges in screening and early diagnosis.
Current Problems in Cancer: Case Reports. Volume 6, June 2022.
Conference Papers
-
Investigating the significance of prior malignancy among patients with primary cutaneous T-cell lymphomas
2023 Jun;
-
Oral Mycobiome Characterization Via Cultivation and Molecular Approaches
2018 Mar;
-
Oral mycobiome characterization via cultivation and molecular approaches
Other
-
Peripheral blood T-cell functional assay as a predictive biomarker of immune-therapy of metastatic melanoma
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
Immunotherapy of cancer: melanoma as a tumor model. Medical Resident Didactic noon talk via Webex | Lecture | 2020 | October 26, University of Connecticut | |
Metastatic melanoma in the elderly Clinical observations and Immunologic insights | Talk | VA | 2018 | VA, West Haven, CT |
Metastatic melanoma in the aging population: clinical and immunologic insights | Talk | National Cancer Center, National Institutes of Heallth | 2018 | Bethesda, MD |
Metastatic melanoma in the elderly: T cell checkpoint blockade and toxicity - does age matter? | Talk | Department of Immunology | 2018 | UCONN, Department of Immunology |
Peripherally induced Tregs or pTregs are the potent tolerance inducer for the growth and metastasis of cancer | Poster | American Association of Cancer Research, Annual Meeting, Chicago, IL 2018 | 2018 | Chicago, IL |
Case Conference 1/6/17 | Lecture | UConn | 2017 | UConn |
Case Conference 4/7/17 | Lecture | UConn | 2017 | UConn |
Case Conference 7/7/17 | Lecture | UConn | 2017 | UConn |
Case Conference 10/6/17 | Lecture | UConn | 2017 | UConn |